Nattokinase

DIETARY_SUPPLEMENT6 trials

Sponsors

Chi Mei Medical Hospital, University of Southern California, Yonsei University, Second Affiliated Hospital, School of Medicine, Zhejiang University, Universidade Federal Fluminense

Conditions

Cardiovascular DiseasesCerebral Blood FlowCognitive FunctionDyslipidemiasHypercholesterolemiaHyperlipidemiaInflammationMetabolic Syndrome

Phase 4

Nattokinase Supplementation and Hemostatic Factors

CompletedNCT02913170

Yonsei UniversityHypercholesterolemia

Start: 2015-05-31End: 2016-09-30Updated: 2016-09-23

Unknown Phase

Efficacy and Safety of Geneferm Nattokinase

CompletedNCT00749801

Chi Mei Medical HospitalHyperlipidemia

Start: 2007-05-31End: 2008-04-30Updated: 2008-09-09

Nattokinase Atherothrombotic Prevention Study

CompletedNCT02080520

University of Southern CaliforniaPrevention of Cognitive Decline, Prevention of Subclinical Atherosclerosis Progression

Start: 2014-04-30End: 2019-07-31Updated: 2024-03-19

Improving Cerebral Blood Flow and Cognitive Function in Patients With Asymptomatic Intracranial / Carotid Stenosis With Nattokinase (ICC-PACS)

Second Affiliated Hospital, School of Medicine, Zhejiang UniversityCerebral Blood Flow, Cognitive Function

Start: 2022-01-13End: 2023-12-31Target: 100Updated: 2023-04-18

Effects of Nattokinase on Inflammation and Cardiovascular Risk Markers in Patients With Dyslipidemia

RecruitingNCT06183307

Universidade Federal FluminenseCardiovascular Diseases, Dyslipidemias, Inflammation

Start: 2024-08-03End: 2026-12-20Target: 48Updated: 2026-05-14

Effects of Nattokinase on Cardiovascular Risk, Gut Microbiota, Sleep, and Cognition in Metabolic Syndrome With Sleep Disorders.

RecruitingNCT07229521

Taipei Medical UniversityMetabolic Syndrome, Sleeping Disorders

Start: 2025-03-15End: 2027-02-11Target: 80Updated: 2025-11-17